the aid library

LIST OPTIONS

Filter

3772

Sort by:

Direction:

Download (136)

View PDF (159)

National Action Plan of the Islamic Republic of Iran for combating antimicrobial resistance

Ministry of Health and Medical Education Iran (2016) C_WHO

Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ... more

Download (102)

View PDF (162)

Belgian Antibiotic Policy Coordination Committee Policy paper for the 2014-2019 term

Erica Balligand, Michiel Costers and Evelyne Van Gastel Belgian Antibiotic Policy Coordination Committee (2014) C2

Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo... more

Download (93)

View PDF (675)

Q&A: Antibiotic resistance: where does it come from and what can we do about it?

Wright G.D. BMC Biology (2010) C2

Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-... more

Download (172)

View PDF (161)

Direct and indirect effects of COVID-19 on maternal and child health in Bangladesh

M. M. Ahmmed; M. A. Babu; J. Ferdosy (2021) CC

Bangladesh has been going through incremental trend of GDP growth rates for a long time. The GDP is the key aspect to measure the economic growth of a country. But the current world wide pandemic due to the COVID-19 hardly affects the world’s economy as well as Bangladesh. The present... more

Download (102)

View PDF (130)

COVID-19 and Food Safety: Guidance for competent authorities responsible for national food safety control systems

World Health Organization WHO (2020) C_WHO

The ongoing COVID-19 pandemic presents an exceptional and unprecedented challenge for competent authoritiesa with responsibilities for national food safety control systemsb to continue conducting routine functions and activities in accordance with national regulations... more

Download (83)

View PDF (154)

COVID-19 e segurança dos alimentos: Orientações para as autoridades competentes responsáveis pelos sistemas de controloda segurança dos alimentos

World Health Organization WHO (2020) C_WHO

A atual pandemia de COVID-19 constitui um desafio excepcional e sem precedentes para que as autoridades competentes, com responsabilidades nos sistemas nacionais de controlo da segurança dos alimentosa, possam continuar a desempenhar as suas funções e atividades ... more

Download (22)

View PDF (22)

Promoting Cardiovascular Health in the Developing World

Institute of Medicine (2010) CC

Cardiovascular disease (CVD) is often thought to be a problem of wealthy, industrialized nations. The term “cardiovascular disease” is used throughout the report to refer to cardiac disease, vascular diseases of the brain and kidney, and peripheral vascular disease. The report’s main focus is ... more

Download (163)

View PDF (151)

Schistosomiasis and soil-transmitted helminthiases: progress report, 2022

World Health Organization WHO (2023) C_WHO

Human schistosomiasis is caused mainly by 3 schistosome species: Schistosoma haematobium, S. mansoni and S. japonicum. S. guineensis, S. intercalatum and S. mekongi have a highly localized distribution in Central Africa and along the Mekong River in South-East Asia, respectively. Soil-transmitted h... more

Download (261)

View PDF (356)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (77)

View PDF (310)

Air Pollution - WHO

World Health Organisation (WHO) (2022) C_WHO

Accessed on 06.03.2022 Air pollution is contamination of the indoor or outdoor environment by any chemical, physical or biological agent that modifies the natural characteristics of the atmosphere. Household combustion devices, motor vehicles, industrial facilities and forest fires are common sou... more

Download (43)

View PDF (32)

Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy

World Health Organisation (WHO) (2023) C_WHO

Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.

Download (143)

View PDF (216)

Policy statement and recommended actions for early detection of breast, cervical, colorectal, oral and prostate cancers in the Eastern Mediterranean Region

World Health Organization WHO; Eastern Mediterranean Region (2022) C_WHO

Policy Statement

Download (580)

View PDF (1312)

Integrating palliative care and symptom relief into primary health care : WHO guide for planners, implementers and managers

World Health Organization WHO (2018) C_WHO

Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p... more

Download (629)

View PDF (1170)

Integrating palliative care and symptom relief into paediatrics: a WHO guide for health-care planners, implementers and managers

World Health Organization WHO (2018) C_WHO

People younger than 20 years comprise 35% of the global population and 40% of the global population of least-developed nations. The number of children - neonates, infants, children, and adolescents up to 19 years of age - who need pediatric palliative care (PPC) each year may be as high as 21 millio... more

Download (125)

View PDF (196)

Joint request for selected preventive chemotherapy medicines and joint reporting form

World Health Organization WHO (2013) C_WHO

User Guide

Download (536)

View PDF (644)

Basic Infection Control And Prevention Plan for Outpatient Oncology Settings

Centers of Disease Control CDC (2011) C_CDC

"This document has been developed for outpatient oncology facilities to serve as a model for a basic infection control and prevention plan. It contains policies and procedures tailored to these settings to meet minimal expectations of patient protections as described in the CDC Guide to Infecti... more

Download (290)

View PDF (360)

India: Guidelines for developing palliative care services

MNJ Institute of Oncology and RCC, Hyderabad Government India; World Health Organization WHO (2008) C_WHO

Recommendations of an Expert Meeting June 2008

Download (94)

View PDF (737)

Breast Care - Brustbewusstsein

Pink Ribbon Deutschland (2021) CC

Projektvorstellung „Breast Care - Brustbewusstsein“ ist eine App für Frauen mit Migrationshintergrund und für jede in Deutschland lebende Frau, der die Chance der Früherkennung von Brustkrebs zugänglich gemacht werden soll. Grundsätzlich werden die Frauen, die in Deutschland leben, durch... more

Download (400)

View PDF (783)

Use of cryotherapy for cervical intraepithelial neoplasia

World Health Organization WHO (2011) C_WHO

Download (75)

View PDF (400)

Krebskranke Geflüchtete aus der Ukraine: Erste Einblicke in die Versorgung in Deutschland

Hermes-Moll, K. et al. Deutsches Ärzteblatt (2023) C2

Die medizinische Versorgung von krebskranken Geflüchteten aus der Ukraine ist hierzulande prinzipiell gewährleistet, wie eine Befragung onkologischer Schwerpunktpraxen zeigt. Dabei bestehen jedoch viele Herausforderungen, die die behandelnden Ärztinnen und Ärzte meistern müssen.